Here in this study, we discovered that the JNK-dependent mechanism of CSC/CSLC maintenance is operative in human pancreatic cancer and demonstrated that the mechanism can be targeted safely and effectively in vivo. Here, MAPK8 is linked to pancreatic neoplasm.